Park Avenue Institutional Advisers

Latest statistics and disclosures from Park Avenue Institutional Advisers's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are RVMD, BRZE, TTAN, and represent 100.00% of Park Avenue Institutional Advisers's stock portfolio.
  • Added to shares of these 3 stocks: RVMD, BRZE, TTAN.
  • Started 3 new stock positions in BRZE, TTAN, RVMD.
  • Reduced shares in these 1 stock: JABS (-$100M).
  • Sold out of its position in JABS.
  • Park Avenue Institutional Advisers was a net seller of stock by $-99M.
  • Park Avenue Institutional Advisers has $1.0M in assets under management (AUM), dropping by -98.99%.
  • Central Index Key (CIK): 0001640801

Tip: Access up to 7 years of quarterly data

Positions held by Park Avenue Institutional Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Park Avenue Institutional Advisers

Park Avenue Institutional Advisers holds 3 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Revolution Medicines Common Stock (RVMD) 40.5 $407k NEW 5.1k 79.65
 View chart
Braze Common Stock (BRZE) 30.3 $305k NEW 8.9k 34.29
 View chart
ServiceTitan Common Stock (TTAN) 29.2 $294k NEW 2.8k 106.50
 View chart

Past Filings by Park Avenue Institutional Advisers

SEC 13F filings are viewable for Park Avenue Institutional Advisers going back to 2015

View all past filings